Biocon Bags Canadian OK for Yesafili After Patent Face-Off

Unknown Apr 02, 2026 1,100 Views

Biocon Biologics has received Health Canada’s tentative approval for Yesafili, its biosimilar to Eylea (aflibercept), clearing a major regulatory hurdle for entry into the Canadian market. The approval follows a settlement with Bayer and Regeneron, the makers of Eylea, resolving multipl...